Intervention not reported
Fatal and non‐fatal stroke ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in fatal and non‐fatal stroke ( (low certainty).
1 finding from 1 review
Fatal or nonfatal stroke · patients with acute coronary syndrome
Statins showed no clear difference in fatal and non‐fatal stroke compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Fatal and non‐fatal ischaemic stroke · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to lower fatal and non‐fatal ischaemic stroke compared with aspirin alone (moderate certainty).
1 finding from 1 review
Stroke · middle‐aged US male physicians
Vitamin C supplementation showed no clear difference in total stroke (fatal and non‐fatal) Physicians compared with placebo (low certainty).
1 finding from 1 review
Clinical CVD events (CVD mortality, non‐fatal MI and stroke, revascularisations) · people at high risk of or withcardiovascular disease
Transcendental meditation (TM) showed no clear difference in clinical CVD events (CVD mortality, non‐fatal MI and stroke,… compared with active comparators (low certainty).
1 finding from 1 review
Fatal or nonfatal stroke · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in stroke (ischaemic or haemorrhagic, non‐fatal or fatal) during the… compared with control (low certainty).
2 findings from 1 review
Stroke, myocardial infarction, or vascular death · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates probably leads to lower composite outcome of non‐fatal stroke, non‐fatal myocardial… compared with control (moderate certainty).
1 finding from 1 review
Combined outcome of non‐fatal myocardial infarction, non‐fatal stroke, and total number of deaths · patients with acute coronary syndrome
Statins showed no clear difference in combined outcome of non‐fatal myocardial infarction, non‐fatal… compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Composite outcome of non‐fatal stroke, non‐fatal myocardial infarction, and vascular death without clofibrate · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in composite outcome of non‐fatal stroke, non‐fatal myocardial… compared with control (low certainty).
1 finding from 1 review
Composite endpoint (including all‐cause mortality, non‐fatal myocardial infarction and/or any new stroke assessed at 30 days after surgery) · people undergoing CABG (with or without valve surgery)
RIPC showed no clear difference in composite endpoint (including all‐cause mortality, non‐fatal… compared with no RIPC (moderate certainty).
1 finding from 1 review